(lp0
S'About: Cyclacel Pharmaceuticals,  Seeking Alpha - Mar 9, 2017 Cyclacel Pharmaceuticals Inc.,  is a small biopharmaceutical company that works on developing oral therapies for the treatment of various cancers and diseases with high unmet medical need.Cyclacel Pharmaceuticals, Inc.  Rises on Publication of Data - StockNewsUnionAnalyst Hints Surrounding Cyclacel Pharmaceuticals, Inc.  - Post Analyst'
p1
aS"Guess Who Cyclacel Pharmaceuticals Inc.  Shares Small Cap Exclusive  - Feb 28, 2017 For those not familiar with the company, Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology.Cyclacel Pharmaceuticals Inc  Upgraded to Buy at Zacks Investment Research - The Cerbat GemCyclacel Pharmaceuticals, Inc.'s  stock price is Worth at $3.42 - Hot Stocks Point"
p2
aS"Cyclacel Pharmaceuticals Inc. CYCC  Wall Street Journal - Feb 11, 2011 News Cyclacel Pharmaceuticals Inc.CYCC. Significant News Only. 03/07/17; Press Release. Cyclacel's CDK Inhibitor CYC065 Causes Anaphase Catastrophe, a Novel Cancer-Specific Mechanism of Action, in Research Published in JNCI."
p3
aS"Cyclacel Pharmaceuticals, Inc.'s  CEO Spiro Rombotis on Q2 2016 Results ... Seeking Alpha - Aug 10, 2016 Good afternoon and welcome to the Cyclacel Pharmaceutical's Second Quarter 2016 Results Conference Call and Webcast. Today's call is being recorded."
p4
aS"Insider Trading Activity Cyclacel Pharmaceuticals, Inc.   Major ... Market Exclusive - Feb 28, 2017 Kevin C Tang , Major Shareholder of Cyclacel Pharmaceuticals, Inc.  reportedly Bought 134,200 shares of the company's stock at an average price of 4.34 for a total transaction amount of $582,428.00 SEC Form.Cyclacel shares fall a quarter on Phase III failure - The Pharma Letter "
p5
aS'Cyclacel Pharmaceuticals Inc  to Issue $0.15 Quarterly Dividend The Cerbat Gem - 9 hours ago Cyclacel Pharmaceuticals logo Cyclacel Pharmaceuticals Inc  declared a quarterly dividend on Wednesday, March 15th.'
p6
aS"Cyclacel's Date With Decitabine Seeking Alpha - Aug 22, 2016 Cyclacel's  long-suffering shareholders will shortly see the outcome of its seemingly endless, so-called Seamless trial of sapacitabine in elderly patients with newly diagnosed acute myeloid leukaemia, after the study finally reached the&nbsp;..."
p7
aS"Here's Why Cyclacel Pharmaceuticals Inc  Could Have A Rough December Market Exclusive - Nov 18, 2016 Cyclacel Pharmaceuticals Inc  soared throughout the US session on Thursday, gaining as much as 60% across the day."
p8
aS'Why Wall Street Is Bullish On Cyclacel Pharmaceuticals Inc.  Scibility Media - Aug 15, 2016 After Cyclacel Pharmaceuticals Inc.  released its 2Q2016 financial results and issued some operational updates, some analysts on Wall Street believe it could be a compelling stock flying under the radar.'
p9
aS"Here's What Happened With Cyclacel Pharmaceuticals Inc  and ... Market Exclusive - Feb 24, 2017 This week was a good one for a few biotechs, but not so great for others. Two in particular have just put out news relating to trials for their lead investigative assets, and both have taken a hit on the back of the release."
p10
a.